At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 93 enrolled
Drug / intervention
Varenicline +1 moredrug
Likely dose
Varenicline 1 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Varenicline for Light Smokers
In Brief
A Phase 4 clinical trial evaluating Varenicline and Placebo for Smoking. Completed, enrolled 93 participants across 1 site.
Detailed Summary
The purpose of this study is to determine if varenicline is effective in treating tobacco dependence in adults who smoke 5-10 cigarettes per day.
Study Details
Timeline
Phase 4CompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedJul 2012
Enrollment StartJan 2013
Primary CompletionDec 2015
Study CompletionJun 2016
TodayJul 2026
First PostedJul 12, 2012
Enrollment StartJan 1, 2013
Primary CompletionDec 1, 2015
Study CompletionJun 1, 2016
TodayJul 2, 2026
Enrollment to primary: 2.9 yearsPosted 14.0 years ago
Interventions
Vareniclinedrug
1 mg of varenicline twice per day for 12 weeks and brief behavioral counseling
Placebodrug
1 placebo tablet twice per day for 12 weeks and brief behavioral counseling